Geoffrey Michael Glass, Director at AVADEL PHARMACEUTICALS PLC (AVDL), bought 45,000 shares at $2.14 ($96K) on 2022-05-31, disclosed to the SEC on 2022-06-03.
Open-market purchase of $96k AVDL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| AVDL | BUY | 2022-06-02 | $96K | — | Filing → |
| AVDL | BUY | 2020-09-01 | $33K | — | Filing → |
| AVDL | BUY | 2020-08-14 | $100K | — | Filing → |